0001551124-16-000002.txt : 20160205 0001551124-16-000002.hdr.sgml : 20160205 20160205140051 ACCESSION NUMBER: 0001551124-16-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160205 DATE AS OF CHANGE: 20160205 EFFECTIVENESS DATE: 20160205 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IVDiagnostics, Inc. CENTRAL INDEX KEY: 0001551124 IRS NUMBER: 273665629 STATE OF INCORPORATION: IN FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-256854 FILM NUMBER: 161391546 BUSINESS ADDRESS: STREET 1: 880 EASTPORT CENTRE DRIVE CITY: VALPARAISO STATE: IN ZIP: 46383 BUSINESS PHONE: 2198400007 MAIL ADDRESS: STREET 1: 880 EASTPORT CENTRE DRIVE CITY: VALPARAISO STATE: IN ZIP: 46383 D 1 primary_doc.xml X0707 D LIVE 0001551124 IVDiagnostics, Inc. 9800 CONNECTICUT DR CROWN POINT IN INDIANA 46307 2198400007 INDIANA None None Corporation true Frank Szczepanski 9800 CONNECTICUT DR CROWN POINT IN INDIANA 46307 Executive Officer Director Joseph Firca 9800 CONNECTICUT DR CROWN POINT IN INDIANA 46037 Executive Officer Director John D. Feczko 9800 CONNECTICUT DR CROWN POINT IN INDIANA 46037 Executive Officer Tom Szczepanski 9800 CONNECTICUT DR CROWN POINT IN INDIANA 46037 Executive Officer Director Joerg Schreiber 9800 CONNECTICUT DR CROWN POINT IN INDIANA 46037 Executive Officer Timothy Blackmun 9800 CONNECTICUT DR CROWN POINT IN INDIANA 46037 Director Robert Center 9800 CONNECTICUT DR CROWN POINT IN INDIANA 46037 Director Robert Johnson 9800 CONNECTICUT DR CROWN POINT IN INDIANA 46037 Director Biotechnology Decline to Disclose 06b false true false true false 0 Livingston Securities, LLC 147364 None None 825 Third Avenue Second Floor New York NY NEW YORK 10022 CA CALIFORNIA FL FLORIDA IL ILLINOIS IN INDIANA MA MASSACHUSETTS MI MICHIGAN MO MISSOURI NY NEW YORK NC NORTH CAROLINA OH OHIO false 4000000 0 4000000 If Issuer raises at least $1000000, the principal and interest then due on certain convertible promissory notes issued by Issuer in the principal amount of approx. $325000 will convert at a discount into the same type of securities issued in this offering false 0 280000 true 0 400000 true Executive officer salaries. false IVDiagnostics, Inc. /s/ Frank Szczepanski Frank Szczepanski President and CEO 2016-02-02